ROBERTA CLAUDINO STEPHENSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PLANO, TX NPI 1669915427
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,572.39
- Category: General Payments
- Program years: PY2024
- Record count: 52
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,572.39 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,373.40 | 50 |
| Education | $198.99 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $211.05 | 5 |
| Janssen Biotech, Inc. | $196.62 | 9 |
| Incyte Corporation | $146.62 | 3 |
| Myriad Genetic Laboratories, Inc. | $119.96 | 2 |
| Genmab U.S., Inc. | $112.88 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $101.69 | 3 |
| SEAGEN INC. | $99.99 | 1 |
| Merck Sharp & Dohme Corporation | $93.88 | 5 |
| Daiichi Sankyo Inc. | $51.41 | 2 |
| Astellas Pharma US Inc | $44.34 | 2 |
| PFIZER INC. | $38.41 | 1 |
| Deciphera Pharmaceuticals Inc. | $32.54 | 1 |
| SOBI, INC | $32.43 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.46 | 1 |
| GENZYME CORPORATION | $28.05 | 1 |
| Karyopharm Therapeutics Inc. | $24.94 | 1 |
| Regeneron Healthcare Solutions, Inc. | $24.80 | 1 |
| GlaxoSmithKline, LLC. | $24.15 | 1 |
| EISAI INC. | $24.09 | 1 |
| ABBVIE INC. | $24.01 | 1 |
| Mirati Therapeutics, Inc. | $23.10 | 1 |
| Lilly USA, LLC | $20.40 | 1 |
| EMD Serono, Inc. | $19.01 | 1 |
| Agios Pharmaceuticals, Inc. | $18.52 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.20 | 1 |
| TAIHO ONCOLOGY, INC. | $13.84 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $1,572.39 | 52 |
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.